FDA.reportPublic FDA data

brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension

RxCUI
1421451
RxNorm name
brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension
Display name
brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension
Full name
brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SIMBRINZABRINZOLAMIDE/BRIMONIDINE TARTRATEAlcon Laboratories, Inc.a49c157e-6310-0011-7b7f-e26fc1820d592025-03-11Warnings, Adverse reactionsExact identifier
rxcui: 1421451

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a49c157e-6310-0011-7b7f-e26fc1820d59brinzolamide 1 % / brimonidine tartrate 0.2 % Ophthalmic Suspension [PSN] · brimonidine tartrate 2 MG/ML / brinzolamide 10 MG/ML Ophthalmic Suspension [SCD] · brimonidine tartrate 0.2 % / brinzolamide 1 % Ophthalmic Suspension [SY]319These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 201320250311